S. Johnson

发表

D. Oscier, R. Owen, S. Johnson, 2005, Blood reviews.

Phase II trial of idarubicin in patients with advanced lymphoma

S. Johnson, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.

U. Jaeger, D. Oscier, V. Leblond, 2005, Clinical lymphoma.

Guidelines on the management of Waldenström macroglobulinaemia *

D. Oscier, R. Owen, S. Johnson, 2006, British journal of haematology.

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

G. Follows, D. Linch, Paul D. Smith, 2016, Haematologica.

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia.

E. Kimby, M. Dimopoulos, D. Maloney, 2006, Clinical lymphoma & myeloma.

Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP

J. Seymour, S. Rule, R. Owen, 2005, Leukemia & lymphoma.

Clinical Pharmacokinetics of Nucleoside Analogues

S. Johnson, 2000, Clinical Pharmacokinetics.

Expression of ZAP‐70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease: response to Smolej et al.

S. Johnson, G. Gibbs, T. Bromidge, 2008 .

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.

E. Kimby, M. Dimopoulos, D. Maloney, 2006, Blood.

Fludarabine for the Treatment of Advanced Chronic Lymphocytic Leukemia: Results of a Prospective Randomized Comparison with Cyclophosphamide, Doxorubicin and Prednisone

W. Hiddemann, B. Emmerich, M. Björkholm, 1997 .

Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies

S. Johnson, W. Thomas, 2000 .

A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation

P. Ganly, R. Marcus, G. Jackson, 2001, British journal of haematology.

G‐CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

D. Winfield, D. Linch, A. Fielding, 1997, British journal of haematology.

Nucleoside analogues in the treatment of haematological malignancies

S. Johnson, S. Johnson, 2001, Expert opinion on pharmacotherapy.

Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis

N. Wareham, J. Goldman, S. Johnson, 2004, Cancer Chemotherapy and Pharmacology.

Oral cladribine for B‐cell chronic lymphocytic leukaemia: report of a phase II trial with a 3‐d, 3‐weekly schedule in untreated and pretreated patients, and a long‐term follow‐up of 126 previously untreated patients

E. Kimby, A. Delannoy, G. Juliusson, 2002, British journal of haematology.

Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay

D. Oscier, J. Orchard, A. G. Bosanquet, 1999, British journal of haematology.

Combination therapy with fludarabine and cyclophosphamide as salvage treatment in lymphoproliferative disorders

S. Johnson, M. Tighe, D. Turner, 1999, British journal of haematology.

Advances in the treatment of Waldenström’s macroglobulinemia

S. Johnson, 2006, Expert review of anticancer therapy.

Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment

G. Morgan, R. Owen, S. Johnson, 2000, Hematological oncology.

Salvage chemotherapy for relapsed and resistant lymphoma with a carboplatin containing schedule—epic

S. Johnson, M. J. Phillips, M. Tighe, 1994, Hematological oncology.

Workshop on Waldenström's Macroglobulinemia Update on treatment recommendations from the Third International

E. Kimby, M. Dimopoulos, D. Maloney, 2008 .

Waldenström's macroglobulinemia.

S. Johnson, 2002, Reviews in clinical and experimental hematology.

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay

S. Richards, A. G. Bosanquet, S. Johnson, 1999, British journal of haematology.

The Addition of Rituximab to Fludarabine and Cyclophosphamide (FC) Improves Overall Survival in Newly Diagnosed Mantle Cell Lymphoma (MCL): Results of the Randomised UK National Cancer Research Institute (NCRI) Trial

G. Follows, D. Linch, Paul D. Smith, 2011 .

p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia.

A. Prentice, S. Johnson, T. Bromidge, 2000 .

p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B‐chronic lymphocytic leukaemia

A. Prentice, S. Johnson, T. Bromidge, 2000, British journal of haematology.

Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial

A. Amato, S. Johnson, D. Pilgrim, 2021, Neurology.

Early evaluation of liposomal daunorubicin (DaunoXome®, Nexstar) in the treatment of relapsed and refractory lymphoma

J. Cavenagh, A. Newland, S. Johnson, 2004, Investigational New Drugs.

Development of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma Clinical Research: The Functional Assessment of Cancer Therapy - Lymphoma (FACT-Lym).

B. Cheson, J. Cashy, D. Cella, 2005 .

Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.

S. Johnson, 2004, The hematology journal : the official journal of the European Haematology Association.

Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

C. Fegan, P. Maguire, D. Oscier, 2004, British journal of haematology.

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.

T. Lister, D. Oscier, J. Orchard, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.

B. Coiffier, W. Hiddemann, T. Lister, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinorelbine: an overview.

G. Hortobagyi, S. Johnson, Pierre Pouillart, 1996, Cancer treatment reviews.